Sormani MP, Häring DA, Kropshofe H, et al. Blood NfL as a potential endpoint in Phase 2 clinical studies in relapsing-remitting multiple sclerosis. ECTRIMS 2017, #277.
Podcast: AI in stroke - Using deep learning to predict clinical outcomes after stroke
jan 2024 | Neuro-vasculair